Buscar resultados de ensayos clínicos
Muscular Atrophy - 110 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Newborn Screening for Spinal Muscular Atrophy Condición: Spinal Muscular Atrophy Fecha: 2014-04-21 Intervenciones: Other: newborn screening test for SMA Routine newborn screening dried blood spots sample is used to test |
Active, not recruiting |
Nombre del estudio: An Open Label Study of LMI070 in Type 1 Spinal Muscular Atrophy (SMA) Condición: Spinal Muscular Atrophy Fecha: 2014-10-01 Intervenciones: Drug: LMI070 |
Completed |
Nombre del estudio: Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Condición: Spinal Muscular Atrophy Fecha: 2007-05-30 Intervenciones:
|
Completed |
Nombre del estudio: Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy Condición: Spinal Muscular Atrophy Fecha: 2006-09-06 Intervenciones: Drug: Valproic Acid |
Enrolling by invitation |
Nombre del estudio: Mechanisms of Cell Death in Spinal Muscular Atrophy Condición: Spinal Muscular Atrophy Fecha: 2012-12-13 |
Completed |
Nombre del estudio: Spinal Muscular Atrophy and Cardiac Autonomic Function Condición: Spinal Muscular Atrophy Fecha: 2012-01-24 Intervenciones: Procedure: Air stacking manuever Electrocardiogram signals were recorded for analyses of heart rate vari |
Completed |
Nombre del estudio: Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe) Condición: Spinal Muscular Atrophy Fecha: 2012-05-30 Intervenciones:
|
Completed |
Nombre del estudio: Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Condición: Spinal Muscular Atrophy Fecha: 2005-09-23 Intervenciones:
|
Completed |
Nombre del estudio: Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy Condición: Spinal Muscular Atrophy Fecha: 2007-09-10 Intervenciones: Drug: Sodium phenylbutyrate (NaPB) The powder form of the drug will be dispensed. The target NaPB dosing |
Active, not recruiting |
Nombre del estudio: A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). Condición: Spinal Muscular Atrophy Fecha: 2015-05-14 Intervenciones:
|